Semaglutide's CHMP Backing Stipulates Post-Approval Safety Studies

 
• By Sten Stovall
Recommended
Novo Nordisk's Ozempic (semaglutide) Gets Recommended For Approval By EMA's CHMP • Source: Shutterstock

More from New Products

More from Scrip